Idursulfase beta

艾度硫酸酯酶 β

Report date: 2025/02/12 10:56:02

Base Information

Drug NameIdursulfase beta
Drug Alias Name艾度硫酸酯酶 β 注射液Recombinant human iduronate-w-sulfatase艾杜硫酯酶βRecombinant human iduronate-2-sulfataseIduronate-2-sulfatase +[18] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionIduronate-2-sulfatase replacements
TargetsIduronate-2-sulfatase
Therapy Area/IndicationsMucopolysaccharidosis II
Global Approved IndicationsMucopolysaccharidosis II
Approved Indications in ChinaMucopolysaccharidosis II
Original Approved Country/TerritorySouth Korea
Original Approved Date2012/01/12
Country/TerritoryRussian FederationSouth KoreaMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGC Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesGC Biopharma CorpCanbridge Life Sciences LtdClinigen Inc +[4] 
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis II
Inactive IndicationsN/A

Other Information

ATC CodeA16AB16
Related LinksWikipediaDrugBank